IRIS
GREPPI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.754
Totale 1.754
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.754
Totale 1.754
Salva come PNG Salva come JPEG
Città #
Genova 1.130
Genoa 313
Rapallo 299
Bordighera 12
Totale 1.754
Salva come PNG Salva come JPEG
Nome #
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 147
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 146
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 118
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 112
Harnessing NK Cells for Cancer Treatment 111
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 108
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 104
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 86
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 74
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 71
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 69
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 62
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 60
Expression, role and regulation of NK cell immune checkpoints (PD-1, KIRs, NKG2A) in Ovarian Cancer 57
New Insights into Endometrial Cancer 56
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 56
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection 51
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 50
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 44
Histopathological And Immunohistochemical Prognostic Factors In High-Grade Non-Endometrioid Carcinomas Of The Endometrium (Hg-Necs). Is It Possible To Identify Sub-Groups At Increased Risk? 43
NK Cell-Based Immunotherapy in Colorectal Cancer 41
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 40
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 29
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 29
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 23
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art 16
Harnessing Immune Response in Acute Myeloid Leukemia 14
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 14
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 12
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers 8
Tumor-Infiltrating Natural Killer Cells 1
Totale 1.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.337
article - articoli 5.139
book - libri 0
conference - conferenze 752
curatela - curatele 0
other - altro 247
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201949 0 0 0 0 0 0 0 0 0 0 27 22
2019/2020456 21 7 8 26 42 62 76 33 49 70 52 10
2020/2021308 18 12 20 12 3 71 3 15 30 52 37 35
2021/2022298 9 9 17 23 28 26 16 61 38 27 17 27
2022/2023359 35 32 6 28 57 44 2 28 70 6 42 9
2023/2024286 13 36 9 43 22 35 33 58 16 21 0 0
Totale 1.852